Biotechnology & Pharmaceuticals Industry |
4 Q |
3 Q |
2 Q |
1 Q |
4 Q |
|
FY 2024 |
2024 |
2024 |
2024 |
FY 2023 |
Y / Y Revenue Quarterly Growth |
-2.45 % |
13.29 % |
12.11 % |
-1.28 % |
-1.86 % |
Sequential Revenue Quarterly Growth |
-0.05 % |
9.63 % |
12.35 % |
-21 % |
14.81 % |
Revenue Growth Overall Ranking Y/Y |
# 79 |
# 13 |
# 11 |
# 62 |
# 53 |
Y / Y Revenue Annual Growth (at the end of Fiscal Year) |
5.11 % |
|
|
|
-10.94 % |
Y / Y Revenue Growth (12 Months at Quarter Ending) |
5.11 % |
5.24 % |
-0.54 % |
-7.13 % |
-10.94 % |
Sequential Revenue Growth (12 Months at Quarter Ending) |
-0.69 % |
3.16 % |
2.74 % |
-0.36 % |
0.55 % |
Revenue Growth Ranking Y/Y (TTM) |
# 42 |
# 40 |
# 58 |
# 81 |
# 93 |
Y / Y Operating Income Quarterly Growth |
32.66 % |
334.8 % |
130.55 % |
- |
-73.91 % |
Sequential Operating Income Quarterly Growth |
62.54 % |
-28.16 % |
- |
- |
170.71 % |
Operating Income Overall Ranking Y/Y |
# 28 |
# 5 |
# 1 |
# 0 |
# 90 |
Y / Y Operating Income Annual Growth (at the end of Fiscal Year) |
-71.94 % |
|
- |
- |
-74.76 % |
Y / Y Operating Income Growth (12 Months trailing by quarter ending) |
-71.94 % |
-92.71 % |
- |
- |
-74.76 % |
Sequential Operating Income Growth (12 Months trailing by quarter ending) |
46.45 % |
- |
- |
- |
-47.32 % |
Operating Income Growth Ranking Y/Y (TTM) |
# 91 |
# 96 |
# 99 |
# 99 |
# 98 |
Y / Y Income from Cont. Ops Quarterly Growth |
-83.67 % |
- |
- |
- |
-78.78 % |
Sequential Income from Cont. Ops Quarterly Growth |
-90.84 % |
402.59 % |
- |
- |
- |
Income from Cont. Ops Overall Ranking Y/Y |
# 87 |
# 0 |
# 0 |
# 0 |
# 87 |
Y / Y Income from Cont. Ops Annual Growth (at the end of Fiscal Year) |
- |
- |
- |
- |
-87.51 % |
Y / Y Income from Cont. Ops Growth (12 Months trailing by quarter ending) |
- |
- |
- |
- |
-87.51 % |
Sequential Income from Cont. Ops Growth (12 Months trailing by quarter ending) |
- |
- |
- |
- |
-68.69 % |
Income from Cont. Ops Growth Ranking Y/Y (TTM) |
# 103 |
# 98 |
# 100 |
# 96 |
# 95 |
Y / Y Net Income Quarterly Growth |
-83.5 % |
- |
- |
- |
-79.09 % |
Sequential Net Income Quarterly Growth |
-90.84 % |
402.44 % |
- |
- |
- |
Net Income Overall Ranking Y/Y |
# 82 |
# 0 |
# 0 |
# 0 |
# 87 |
Y / Y Net Income Annual Growth (at the end of Fiscal Year) |
- |
- |
- |
- |
-87.6 % |
Y / Y Net Income Growth (12 Months trailing by quarter ending) |
- |
- |
- |
- |
-87.6 % |
Sequential Net Income Growth (12 Months trailing by quarter ending) |
- |
- |
- |
- |
-68.94 % |
Net Income Growth Ranking Y/Y (TTM) |
# 94 |
# 97 |
# 100 |
# 101 |
# 94 |
Y / Y Free Cash Flow Quarterly Growth |
252.42 % |
169.29 % |
-45.24 % |
2002.95 % |
-58.2 % |
Sequential Free Cash Flow Quarterly Growth |
38.03 % |
146.21 % |
104.88 % |
-51.62 % |
1.25 % |
Free Cash Flow Overall Ranking Y/Y |
# 4 |
# 5 |
# 92 |
# 13 |
# 91 |
Y / Y Free Cash Flow Annual Growth (at the end of Fiscal Year) |
71.35 % |
|
|
|
-50.75 % |
Y / Y Free Cash Flow Growth (12 Months trailing by quarter ending) |
71.35 % |
0.15 % |
-38.43 % |
-38.12 % |
-50.75 % |
Sequential Free Cash Flow Growth (12 Months trailing by quarter ending) |
41.14 % |
33.13 % |
-14.6 % |
6.44 % |
-18.14 % |
Free Cash Flow Growth Ranking Y/Y (TTM) |
# 8 |
# 59 |
# 98 |
# 97 |
# 101 |
Y / Y Capital Expenditures Quarterly Growth |
34.45 % |
3.67 % |
-22.2 % |
-8.44 % |
10.82 % |
Sequential Capital Expenditures Quarterly Growth |
54.65 % |
5.8 % |
-7.85 % |
-11.9 % |
17.19 % |
Capital Expenditures Overall Ranking Y/Y |
# 15 |
# 39 |
# 90 |
# 66 |
# 44 |
Y / Y Capital Expenditures Annual Growth (at the end of Fiscal Year) |
3.5 % |
|
|
|
13.42 % |
Y / Y Capital Expenditures Growth (12 Months trailing by quarter ending) |
3.5 % |
5.34 % |
7.72 % |
14.14 % |
13.42 % |
Sequential Capital Expenditures Growth (12 Months trailing by quarter ending) |
10.94 % |
0.35 % |
-4.77 % |
-2.33 % |
14.2 % |
Capital Expenditures Growth Ranking Y/Y (TTM) |
# 58 |
# 54 |
# 58 |
# 52 |
# 63 |